Eurofins Companies Launch SARS-CoV-2 Variant XBB.1.5 Droplet Digital PCR Assay (ddPCR) for Wastewater Surveillance
February 20 2023 - 8:00AM
Business Wire
Highly sensitive ddPCR analytical tool helps
identify rapidly increasing SARS-CoV-2 Variant of Concern, XBB.1.5,
in wastewater samples domestically and internationally, expanding
the comprehensive SARS-CoV-2 wastewater monitoring platform of the
Eurofins network
Eurofins Environment Testing Northern California: Wastewater
(EWW) and Eurofins Pandemic Prevention Services (EPPS) today
launched a droplet digital PCR (ddPCR) assay for the quantitative
analysis of SARS-CoV-2 Variant of Concern (VoC) XBB.1.5 in
wastewater.
The XBB.1.5 VoC is differentiated from other SARS-CoV-2 variants
currently circulating through identification of a single point
mutation. This development furthers the strategic initiative of
Eurofins (Paris:ERF) companies to continually monitor novel VoCs
showing significant incidence within the U.S. and respond to the
rapidly changing landscape of the SARS-CoV-2 pandemic.
Variant XBB.1.5 currently comprises >74% of U.S. SARS-CoV-2
variant distribution and has seen a minimum 10% weekly increase in
national prevalence since January 2023. The Eastern U.S. currently
has a notably high presence of XBB.1.5, specifically in HHS Region
1 (93%), Region 2 (95%), and Region 3 (85%). The World Health
Organization has stated that, along with BQ.1 variants, XBB
variants are the most antibody-resistant SARS-CoV-2 variants to
date, but do not carry any mutation known to be associated with a
potential change in severity.
Empowering community leaders and stakeholders to make
evidence-based decisions is central to the Eurofins wastewater
surveillance offering - accomplished through robust scientific
techniques, complete project development/support, and access to
teams of established industry experts in wastewater
epidemiology.
Governments, public institutions, and businesses have leveraged
wastewater monitoring to protect the populations they serve,
Eurofins companies offer technical expertise and support to ensure
their strategies and mitigation efforts remain effective.
Key Features
- Adaptable, scalable wastewater monitoring platform for total
SARS-CoV-2 and currently circulating VoCs.
- Project development and ongoing professional support from the
global Eurofins network of wastewater monitoring experts.
- ddPCR platform provides analytical sensitivity unobtainable
through other biological monitoring methods.
- 72-hour data turnaround time provides a near real-time source
of community health information.
- Immediate availability of EPPS’ ddPCR wastewater monitoring
platform and project design services.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With 61,000 staff across a network
of 940 laboratories in 59 countries, Eurofins’ companies offer a
portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230220005021/en/
Further information: Brooke Maharg
Brooke.Maharg@ET.EurofinsUS.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024